These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 28672282)

  • 1. Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study.
    Ma GK; Brensinger CM; Wu Q; Lewis JD
    Ann Intern Med; 2017 Aug; 167(3):152-158. PubMed ID: 28672282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Outcomes Following Multiply Recurrent Clostridioides difficile Infection and Fecal Microbiota Transplantation.
    Dawwas GK; Brensinger CM; Vajravelu RK; Wu Q; Kelly CR; Laine L; Wu GD; Lewis JD
    Clin Gastroenterol Hepatol; 2022 Apr; 20(4):806-816.e6. PubMed ID: 33307184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation and Clostridioides difficile infection among privately insured patients in the United States.
    El Halabi J; Palmer N; Fox K; Kohane I; Farhat MR
    J Gastroenterol; 2022 Jan; 57(1):10-18. PubMed ID: 34495400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes.
    Haines CF; Moore RD; Bartlett JG; Sears CL; Cosgrove SE; Carroll K; Gebo KA
    AIDS; 2013 Nov; 27(17):2799-807. PubMed ID: 23842125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
    Kelly CR; Khoruts A; Staley C; Sadowsky MJ; Abd M; Alani M; Bakow B; Curran P; McKenney J; Tisch A; Reinert SE; Machan JT; Brandt LJ
    Ann Intern Med; 2016 Nov; 165(9):609-616. PubMed ID: 27547925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients.
    Abu-Sbeih H; Choi K; Tran CN; Wang X; Lum P; Shuttlesworth G; Stroehlein JR; Okhuysen PC; Wang Y
    Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):128-134. PubMed ID: 30339561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Patients With Initial
    Guh AY; Li R; Korhonen L; Winston LG; Parker E; Czaja CA; Johnston H; Basiliere E; Meek J; Olson D; Fridkin SK; Wilson LE; Perlmutter R; Holzbauer SM; D'Heilly P; Phipps EC; Flores KG; Dumyati GK; Pierce R; Ocampo VLS; Wilson CD; Watkins JJ; Gerding DN; McDonald LC
    Open Forum Infect Dis; 2024 Apr; 11(4):ofae127. PubMed ID: 38577028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of recurrent Clostridium difficile infection in out-patients.
    Shivashankar R; Khanna S; Kammer PP; Scott Harmsen W; Zinsmeister AR; Baddour LM; Pardi DS
    Aliment Pharmacol Ther; 2014 Sep; 40(5):518-22. PubMed ID: 25039269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile infection in hospitalized children in the United States.
    Nylund CM; Goudie A; Garza JM; Fairbrother G; Cohen MB
    Arch Pediatr Adolesc Med; 2011 May; 165(5):451-7. PubMed ID: 21199971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with the Use of Fecal Microbiota Transplant in Patients with Recurrent Clostridium difficile Infections.
    Jamot S; Raghunathan V; Patel K; Kelly CR; Lim SH
    Infect Control Hosp Epidemiol; 2018 Mar; 39(3):302-306. PubMed ID: 29363436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-Specific Risk for Community-Acquired
    Zhang J; Chen L; Gomez-Simmonds A; Yin MT; Freedberg DE
    Antimicrob Agents Chemother; 2022 Dec; 66(12):e0112922. PubMed ID: 36377887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital.
    Aldrich AM; Argo T; Koehler TJ; Olivero R
    Pediatr Infect Dis J; 2019 Jan; 38(1):32-36. PubMed ID: 29601446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative epidemiology of Clostridium difficile infection: England and the USA.
    King A; Mullish BH; Williams HRT; Aylin P
    Int J Qual Health Care; 2017 Oct; 29(6):785-791. PubMed ID: 29025123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.
    de Blank P; Zaoutis T; Fisher B; Troxel A; Kim J; Aplenc R
    J Pediatr; 2013 Sep; 163(3):699-705.e1. PubMed ID: 23477996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of and risk factors for recurrent Clostridioidesdifficile infection in Japan using a claims database: A retrospective cohort study.
    Mikamo H; Kondo T; Okuyama K; Marcella SW; Ruzicka DJ
    Anaerobe; 2020 Feb; 61():102139. PubMed ID: 31830597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Proton Pump Inhibitor Therapy and the Associated Risk of Recurrent Clostridium difficile Infection.
    McDonald EG; Milligan J; Frenette C; Lee TC
    JAMA Intern Med; 2015 May; 175(5):784-91. PubMed ID: 25730198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.